Even though price cut playing cards can help reduce the burden of higher drug charges during the short-term, they do not address the systemic difficulties driving up prescription costs in the U.S. Broader policy improvements could deal with the foundation causes of soaring drug costs, such as deficiency of transparency in pricing and also the purpo